Amplity

Overview

Amplity is a contract medical and commercial organization for biopharma teams that need deployed people, medical expertise, and field intelligence without buying a full commercialization bundle. The company traces its current shape to the Publicis Health spin-off and a PE-backed roll-up that folded in Middleton Access for payer / national-account depth and consolidated multiple outsourced-engagement assets under one operating name. Buyers searching Amplity Health, Publicis Touchpoint Solutions, or Middleton Access should evaluate Amplity as the current entity.

The practical shortlist question is whether a manufacturer needs a focused deployment partner or a broader hub, specialty pharmacy, or agency stack. Amplity is strongest when the launch plan already has a hub, distribution, or agency architecture, but still needs specialized commercial and medical roles in market: contract sales teams, hybrid reps, remote engagement, field reimbursement, MSLs, precision medicine liaisons, lab science liaisons, nurse educators, medical communications, and learning programs. Amplity is not a hub, specialty pharmacy, distributor, or full-service commercialization platform.

Field Force Sales Ops Capability Model

The framework below standardizes how Rx Almanac evaluates field-force-sales-ops capabilities, so buyers can compare vendors like-for-like while the readout column stays vendor-specific. For this table, Amplity is evaluated as contract medical and commercial organization for biopharma teams that need deployed people, medical expertise, and field intelligence without buying a full commercialization bundle.

Capability	Buyer should compare	Amplity readout
Field team deployment and recruiting	Recruiting, hiring, territory coverage, credentialing, onboarding, and speed to deploy.	Core field execution. Amplity offers contract sales, hybrid reps, specialty sales talent, MSLs, precision medicine liaisons, lab science liaisons, nurse educators, and patient-support teams.
Sales, nurse, FRM, and MSL role specialization	Role-specific talent for sales, nurse educators, field reimbursement, medical, and hybrid teams.	Core medical-affairs work. The public service set spans contract sales, field reimbursement, patient support, remote engagement, MSL outsourcing, and medical communications.
CRM, targeting, and activity analytics	CRM operations, call planning, targeting, activity reporting, incentive tracking, and field dashboards.	Documented, validate scope. AnswerY / AskX gives Amplity a proprietary field-insight story; confirm data feeds, dashboards, consent model, and integration boundaries in the SOW.
Training, compliance, and call quality	Product training, compliance monitoring, call quality, certification, and coaching.	Core training and quality controls. Learning solutions, medical communications, and remote engagement support should be scoped with role-specific onboarding, quality review, and compliance governance.
Non-personal and hybrid engagement	Inside sales, remote detailing, digital engagement, virtual meetings, and omnichannel field coordination.	Core hybrid engagement. Amplity’s Remote Engagement Center and hybrid-rep model support lower-reach accounts, access-constrained territories, and programs where in-person coverage is too expensive.
Launch flex capacity and territory design	Pilot teams, surge capacity, vacancy coverage, white-space coverage, and territory redesign.	Strong fit. Amplity is best used for launch strike forces, flexible coverage, specialty role deployment, and programs that may need to expand or contract after initial uptake signals.

Buyer Fit

• Procurement trigger: Use Amplity when the manufacturer needs outsourced field, medical, or access roles faster than it can hire, train, and govern internally.
• Therapy and product fit: Current metadata points to Oncology, Rare Disease, Immunology/Autoimmune, and Neurology; drug-type fit includes Specialty, Biologics, and Small Molecule.
• Commercial fit: Pricing is Custom/RFP, so assume role mix, territories, service levels, data feeds, call-quality review, and governance must be specified in the statement of work.
• Pairing logic: Amplity can sit beside a separate hub, specialty pharmacy, distribution, agency, or analytics vendor. It is less likely to be the single prime contractor for an end-to-end commercialization stack.
• Launch diligence: Confirm attrition, recruiting timelines, co-employment boundaries, medical / promotional separation, data rights, AI governance, and field-to-access handoffs.

Differentiators

• Deployment breadth without full-stack lock-in: Amplity covers contract sales, hybrid reps, remote engagement, FRMs, MSLs, nurse educators, and medical communications without requiring a buyer to outsource the entire commercialization model.
• Medical-affairs depth: Public materials support MSL outsourcing, precision medicine liaisons, lab science liaisons, patient-support teams, and medical communications, which makes the medical-affairs overlay appropriate.
• Market access adjacency: Middleton Access adds payer, national account, pricing, and federal access expertise, while Amplity’s field reimbursement roles connect that access work to provider execution.
• Remote engagement maturity: The Remote Engagement Center gives Amplity a named channel for inside sales, hybrid engagement, and phone-based pharmaceutical support.
• AnswerY / AskX insight layer: The data platform and AI search tool help position Amplity as more than outsourced labor; buyers should still diligence data provenance, permissions, and practical workflow use.

RFP Questions

• Which roles will be Amplity-employed, manufacturer-employed, or shared, and how will co-employment risk be controlled?
• What recruiting timeline, replacement SLA, attrition benchmark, and territory ramp plan apply by role?
• How are medical, commercial, FRM, and patient-support teams separated for compliance while still sharing appropriate account-level signals?
• What call-quality, medical review, training certification, and adverse-event escalation processes are included?
• Which AnswerY / AskX outputs will the manufacturer receive, who owns derivative insights, and how are data permissions, privacy, and AI explainability handled?
• How will field activity, access barriers, and patient-services signals flow into one launch operating cadence?
• What expansion, contraction, or territory-redesign rights are available if launch uptake differs from the forecast?

Recent Activity

• Feb 2024 - Announced CEO transition to Chris Baker; company said it had 90+ medical and commercial programs under management in 41 countries and entered 2024 with 20% greater backlog year over year.
• Jun 2024 - Published NSCLC biomarker-testing research using AnswerY, described as a HIPAA-compliant real-world database of transcribed physician notes.
• Sep 2024 - Public materials highlighted Remote Engagement Center recognition, medical-solutions leadership, national-account market-access leadership, and AskX PM360 innovation coverage.
• Jan 2025 - Rebranded its AI-powered insights platform as AnswerY, consolidating the prior Insights / Xplore naming into one product story.
• Jan 2026 - Joined the American Heart Association Center for Health Technology & Innovation Innovators’ Network, reinforcing the current tech-enabled positioning.